click below
click below
Normal Size Small Size show me how
ID 4
| Pharmacologic Category | Generic | Brand | Classification | Indication | Key side effects | US Boxed warnings | Other Notes |
|---|---|---|---|---|---|---|---|
| Allylamine antifungal | terbinafine (PO, topical) | Lamisil | Topical: OTC | Onychomycosis | nausea, abdominal pain, diarrhea, elevated hepatic transaminases, headache | N/A | N/A |
| Azole antifungal | fluconazole (PO, IV) | Diflucan | N/A | Vulvovaginal candidiasis, oropharyngeal candidiasis, invasive candidiasis | nausea, abdominal pain, diarrhea, QTc prolongation, elevated hepatic transaminases | N/A | N/A |
| Azole antifungal | ketoconazole (PO, topical) | Nizoral | Topical: OTC | Tinea infections | nausea, abdominal pain, diarrhea, QTc prolongation, increased hepatic transaminases | serious hepatotoxicity, including cases with a fatal outcome or requiring liver transplantation have occurred; may cause QTc prolongation and drug interactions leading to QTc prolongation | N/A |
| Polyene antifungal | nystatin (PO) | --- | N/A | Oropharyngeal candidiasis | phlebitis, diarrhea, vomiting, anemia, fever | N/A | N/A |
| Polyene antifungal | nystatin (topical) | Nystop | N/A | Cutaneous and mucocutaneous fungal infections | burning, itching | N/A | only use oral solutions for thrush |
| Echinocandin antifungal | micafungin (IV) | Mycamine | N/A | Invasive candidiasis | no major side effects | N/A | N/A |
| Glucocorticoid and azole antifungal | betamethasone and clotrimazole (topical) | Lotrisone | N/A | Cutaneous fungal infections | burning, itching, dryness, skin atrophy | N/A | do not use for diaper dermatitis; adrenal suppression with long-term use over large areas of skin |
| Neuraminidase inhibitor antiviral | oseltamivir (PO) | Tamiflu | N/A | Influenza | nausea, vomiting, neuropsychiatric events (i.e., confusion, delirium, hallucinations) in pediatric patients (rare) | N/A | N/A |
| Antiviral | acyclovir (PO, IV) | Zovirax | N/A | Herpes simplex virus | nausea, increased hepatic transaminases, crystalluria | N/A | vesicant |
| Antiviral | valacyclovir (PO) | Valtrex | N/A | Herpes simplex virus | nausea, increased hepatic transaminases | N/A | N/A |
| Antiviral | nirmatrelvir + ritonavir (PO) | Paxlovid | N/A | COVID-19 | diarrhea, dysgeusia | significant drug interactions; strong CYP3A inhibitor | N/A |
| Antiviral | remdesivir (IV) | Veklury | N/A | COVID-19 | hyperglycemia, renal impairment | N/A | N/A |
| Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (NRTI) | emtricitabine + tenofovir disoproxil fumarate (PO) | Truvada | N/A | HIV Infection, PreP, PEP | decreased bone mineral density, kidney injury, nausea, diarrhea | post treatment acute exacerbation of hepatitis B, risk of drug resistance with use for preexposure prophylaxis | N/A |
| Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (NRTI) and Integrase strand transfer inhibitor (INSTI) | emtricitabine (NRTI) + tenofovir alafenamide (NRTI) + bictegravir (INSTI) (PO) | Biktarvy | N/A | HIV infection | increased serum bilirubin, headache, weight gain, insomnia, diarrhea, nausea | post treatment acute exacerbation of hepatitis B | take oral INSTIs 2 hours before or 6 hours after products containing calcium, aluminum, magnesium, or iron |